Cellromax Science Co., Ltd. (KOSDAQ:471820)
 5,320.00
 -30.00 (-0.56%)
  At close: Oct 21, 2025
Cellromax Science Statistics
Total Valuation
KOSDAQ:471820 has a market cap or net worth of KRW 58.29 billion. The enterprise value is 46.16 billion.
| Market Cap | 58.29B | 
| Enterprise Value | 46.16B | 
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 | 
| Ex-Dividend Date | Sep 29, 2025 | 
Share Statistics
KOSDAQ:471820 has 11.32 million shares outstanding.
| Current Share Class | 11.32M | 
| Shares Outstanding | 11.32M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | 80.01% | 
| Owned by Institutions (%) | 5.23% | 
| Float | 2.26M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | n/a | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
| Current Ratio | n/a | 
| Quick Ratio | n/a | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | n/a | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | n/a | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | n/a | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | 35 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
| Beta (5Y) | n/a | 
| 52-Week Price Change | n/a | 
| 50-Day Moving Average | 5,696.60 | 
| 200-Day Moving Average | 5,318.90 | 
| Relative Strength Index (RSI) | 38.18 | 
| Average Volume (20 Days) | 41,275 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | n/a | 
| Pretax Income | n/a | 
| Net Income | n/a | 
| EBITDA | n/a | 
| EBIT | n/a | 
| Earnings Per Share (EPS) | n/a | 
Balance Sheet
| Cash & Cash Equivalents | n/a | 
| Total Debt | n/a | 
| Net Cash | n/a | 
| Net Cash Per Share | n/a | 
| Equity (Book Value) | n/a | 
| Book Value Per Share | n/a | 
| Working Capital | n/a | 
Cash Flow
| Operating Cash Flow | n/a | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.68%.
| Dividend Per Share | 35.00 | 
| Dividend Yield | 0.68% | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | 1 | 
| Payout Ratio | n/a | 
| Buyback Yield | n/a | 
| Shareholder Yield | 0.67% | 
| Earnings Yield | n/a | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | n/a |